Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MARRUBIN is a traditional herbal medicinal product developed and manufactured by the German company Repha GmbH Biologische Arzneimittel. The active ingredient is a fluid extract derived from white horehound (*Marrubium vulgare* L.), which contains the bitter diterpene marrubiin as its primary bioactive constituent. It is indicated as an expectorant for the dissolution of mucus in productive coughs associated with the common cold and respiratory infections. The product is formulated as oral drops and is classified under the ATC code R05CP16. It is available over-the-counter in Germany and is produced through controlled cultivation and manufacturing processes entirely within the country.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MARRUBIN.